Form D · Biotechnology

ClearPoint Neuro, Inc.

Solana Beach, CA · CIK 0001285550

Offering snapshot reported Feb 5, 2026 · SEC filing

Reported sold
$17.9M
Offering amount: $17.9M
Investors reported
46
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Nov 20, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 5, 2026Initial$17,892,698No comparison46SEC filing
May 29, 2019Initial$7,522,000No comparison17SEC filing
Jun 6, 2017Initial$13,250,000No comparison60SEC filing
Sep 13, 2016Initial$6,005,000No comparison24SEC filing
Dec 21, 2015Initial$5,294,000No comparison57SEC filing
Dec 23, 2014Initial$10,175,550No comparison74SEC filing
Apr 1, 2014Amendment$3,725,000No comparison10SEC filing
Mar 12, 2014InitialYet to sellNo comparison0SEC filing
Feb 7, 2013Initial$11,042,021No comparison47SEC filing
Jul 16, 2012Initial$6,000,000No comparison65SEC filing
Oct 21, 2011Initial$150,000No comparison1SEC filing
Sep 14, 2011Amendment$1,310,000$810,000vs Jul 15, 20116SEC filing
Jul 15, 2011Initial$500,000No comparison2SEC filing
Oct 22, 2010InitialYet to sellNo comparison0SEC filing
Mar 4, 2010InitialYet to sellNo comparison0SEC filing
Nov 6, 2009Initial$2,000,000No comparison1SEC filing
Apr 11, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jan 11, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Sep 19, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
$0
Finders' fees
$0
Form D file number
021-572443
Calculated based on closing price of common stock on closing date of merger. Includes up to 205,000 shares of common stock that may be cancelled to satisfy obligations of former equityholders of IRRAS Holdings, Inc. under merger agreement.

Source: Form D, filed Feb 5, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Lenox Baker Director
Carol J. Barbre Executive
Paul Bottomely Director
Paul A. Bottomley Director
Joseph M. Burnett Director, Executive
David W. Carlson Executive
Bruce C. Conway Director
Danilo D'alessandro Executive
Lynnette C. Fallon Director
R. John Fletcher Director
Pascal E.R. Girin Director
Francis P. Grillo Director, Executive
Harold A. Hurwitz Executive
Kimble L. Jenkins Director
B. Kristine Johnson Director
Jenkins L. Kimble Director, Executive
Matthew B. Klein Director
Charles E. Koob Director
Robert C. Korn Executive
Linda M. Liau Director
James K. Malernee, Jr. Director
Wendelin Maners Executive
Parker H. Petit Director
Michael A. Pietrangelo Director
Peter G. Piferi Executive
Philip A. Pizzo, M.D. Director
Philip A. Pizzo, M.D. Director
Timothy T. Richards Director
Timothy T. Richards Director
Andrew K. Rooke Director
Michael J. Ryan Director
Mazin Sabra Executive
Maria Sainz Director
Marcio Souza Director
John N. Spencer, Jr. Director
Jeremy L. Stigall Executive
Oscar L. Thomas Executive
John Thomas Director, Executive
Oscar L. Thomas, Jr. Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
120 S. Sierra Avenue Suite 100
Solana Beach, CA, 92075